基于自然语言处理的理赔数据停药算法验证框架
研究利用自然语言处理(NLP)辅助病历审查,从电子健康记录(EHR)中确定抗精神病药、苯二氮䓬类、华法林或直接口服抗凝药的停药参考标准,并评估基于理赔数据的停药算法(处方间隙>15-90天)的灵敏度、特异度和预测值。结果显示不同药物的理赔算法准确性存在差异,NLP验证框架具有可扩展性和实用性。
要点
- 基于理赔数据的停药算法准确性因药物而异。
- 90天间隙算法的灵敏度较低(0.33-0.47),特异度较高(0.75-0.87)。
- 15天间隙算法灵敏度较高(0.58-0.71),但特异度较低(0.45-0.64)。
核心结论
- 基于理赔数据的停药算法整体准确性因药物不同而异。
- NLP辅助的验证框架可扩展用于多种药物的停药评估。
研究设计与样本
- 研究纳入2007-2020年Mass General Brigham EHR中36,656例使用抗精神病药、苯二氮䓬类、华法林或直接口服抗凝药的患者,并链接97,900条Medicare Part D理赔数据。
- 采用NLP辅助的病历审查确定EHR中的停药作为参考标准,评估基于理赔数据的停药算法(处方间隙>15-90天)的灵敏度、特异度和预测值。
主要发现
- 90天间隙算法的灵敏度与特异度:氟哌啶醇0.46和0.79,非典型抗精神病药0.41和0.85,苯二氮䓬类0.47和0.75,华法林0.33和0.80,直接口服抗凝药0.38和0.87。
- 15天间隙算法的灵敏度与特异度:氟哌啶醇0.68和0.55,非典型抗精神病药0.59和0.62,苯二氮䓬类0.71和0.45,华法林0.61和0.49,直接口服抗凝药0.58和0.64。
- 阳性预测值主要受药物停药率影响,受间隙长度影响较小。
关键数值与推荐
- 理赔数据中停药定义为处方间隙大于15-90天。
- 灵敏度、特异度和预测值以NLP辅助病历审查确定的EHR停药为参考标准进行测量。
临床怎么用
- 临床药学智能体在解读理赔数据停药信号时,需考虑药物特异性算法性能差异。
- 可借鉴NLP验证框架,结合EHR数据校准停药判断,提高用药随访准确性。
局限性
- 研究仅纳入四种药物类别,结果外推需谨慎。
- 理赔算法性能受停药率影响,不同人群应用时需重新验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Measuring medication discontinuation in claims data primarily relies on the gaps between prescription fills, but such definitions are rarely validated. This study aimed to establish a natural language processing (NLP)-based validation framework to evaluate the performance of claims-based discontinuation algorithms for commonly used medications against NLP-based reference standards from electronic health records (EHRs). A total of 36,656 patients receiving antipsychotic medications (APMs), benzodiazepines (BZDs), warfarin, or direct oral anticoagulants (DOACs) were identified from the Mass General Brigham EHRs in 2007-2020. These EHR data were linked with 97,900 Medicare Part D claims. An NLP-aided chart review was applied to determine medication discontinuation from EHR (reference standard). In claims data, discontinuation was defined by having a prescription gap larger than 15-90 days (claims-based algorithms). Sensitivity, specificity, and predictive values of claims-based algorithms against the reference standard were measured. The sensitivity and specificity of 90-day-gap-based algorithms were 0.46 and 0.79 for haloperidol, 0.41 and 0.85 for atypical APMs, 0.47 and 0.75 for BZDs, 0.33 and 0.80 for warfarin, and 0.38 and 0.87 for DOACs, respectively. The corresponding estimates for 15-day-gap-based algorithms were 0.68 and 0.55 for haloperidol, 0.59 and 0.62 for atypical APMs, 0.71 and 0.45 for BZDs, 0.61 and 0.49 for warfarin, and 0.58 and 0.64 for DOACs, respectively. Positive predictive values were primarily affected by medication discontinuation rates and less by gap lengths. The overall accuracy of claims-based discontinuation algorithms differs by medications. This study demonstrates the scalability and utility of the NLP-based validation framework for multiple medications.
引用
- Yang CT, Ngan K, Kim DH, et al. Establishing a Validation Framework of Treatment Discontinuation in Claims Data Using Natural Language Processing and Electronic Health Records. Clin Pharmacol Ther. 2025. PMID: 40197528. doi:10.1002/cpt.3650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。